We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | 장 마감 후 (AMC) | $1.1 | — | — | $783.82M | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $0.54 | — | — | $598.12M | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $0.56 | — | — | $1.86B |
Consensus PT $111.08 · 12 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 09. | RBC Capital | — | 의견 유지 | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 05. 08. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $0.18 | — | — | $1.24B | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Stored first · Google News · Yahoo Finance (English)
GMED's Robotics Leasing Shift Could Build Recurring Revenue - Yahoo Finance
GMED's Robotics Leasing Shift Could Build Recurring Revenue Yahoo Finance
Globus Medical Inc - A (NYSE:GMED) Shines in Decent Value Screen with Strong Fundamentals - ChartMill
Globus Medical Inc - A (NYSE:GMED) Shines in Decent Value Screen with Strong Fundamentals ChartMill
GMED Growth Drivers After NuVasive and What Q1 Signals - Zacks Investment Research
GMED Growth Drivers After NuVasive and What Q1 Signals Zacks Investment Research
Globus Medical Inc (GMED) Shares Fall 3.0% -- What GF Score of 9 - GuruFocus
Globus Medical Inc (GMED) Shares Fall 3.0% -- What GF Score of 9 GuruFocus
Looking for a growth stock? 3 reasons why Globus Medical (GMED) is a solid choice - MSN
Looking for a growth stock? 3 reasons why Globus Medical (GMED) is a solid choice MSN